Clinical Trial Detail

NCT ID NCT01358331
Title A Study of the Safety, Tolerability, and Efficacy of MK-8353 in Participants With Advanced Solid Tumors (MK-8353-001)
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Merck Sharp & Dohme Corp.
Indications

melanoma

Advanced Solid Tumor

colorectal cancer

Therapies

MK-8353

Age Groups: adult senior

No variant requirements are available.